GlassScriptPhysician profile
Christina L Midkiff
NPI 1306825856
$4,204.28
in general payments reported to CMS, 2019-2025
44 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $629 · 2021: $877 · 2022: $587 · 2023: $707 · 2024: $284 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $657.69 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $567.41 | 2021-2025 | |
| Abbvie INC. | $483.82 | 2019-2025 | |
| Organon LLC | $178.48 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $176.94 | 2019-2025 | Slynd |
| Exact Sciences Corporation | $146.94 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $136.13 | 2019-2025 | Evenity, Prolia |
| Agile Therapeutics, INC. | $126.63 | 2021-2023 | Twirla |
| Hologic Sales and Service, LLC | $117.41 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $117.36 | 2019-2023 | |
| Myovant Sciences INC. | $116.63 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $116.51 | 2023-2024 | Myfembree |
| Radius Health, INC. | $111.90 | 2019-2025 | Tymlos |
| Astellas Pharma US INC | $98.50 | 2023-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $93.82 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Midkiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.